Titre : Processus néoplasiques

Processus néoplasiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Protein Processing, Post-Translational
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Processus néoplasiques : Questions médicales les plus fréquentes", "headline": "Processus néoplasiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Processus néoplasiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-18", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Processus néoplasiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Processus pathologiques", "url": "https://questionsmedicales.fr/mesh/D010335", "about": { "@type": "MedicalCondition", "name": "Processus pathologiques", "code": { "@type": "MedicalCode", "code": "D010335", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anaplasie", "alternateName": "Anaplasia", "url": "https://questionsmedicales.fr/mesh/D000708", "about": { "@type": "MedicalCondition", "name": "Anaplasie", "code": { "@type": "MedicalCode", "code": "D000708", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.045" } } }, { "@type": "MedicalWebPage", "name": "Carcinogenèse", "alternateName": "Carcinogenesis", "url": "https://questionsmedicales.fr/mesh/D063646", "about": { "@type": "MedicalCondition", "name": "Carcinogenèse", "code": { "@type": "MedicalCode", "code": "D063646", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.098" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Transformation cellulaire néoplasique", "alternateName": "Cell Transformation, Neoplastic", "url": "https://questionsmedicales.fr/mesh/D002471", "about": { "@type": "MedicalCondition", "name": "Transformation cellulaire néoplasique", "code": { "@type": "MedicalCode", "code": "D002471", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.098.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Crise blastique", "alternateName": "Blast Crisis", "url": "https://questionsmedicales.fr/mesh/D001752", "about": { "@type": "MedicalCondition", "name": "Crise blastique", "code": { "@type": "MedicalCode", "code": "D001752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.098.500.110" } } } ] }, { "@type": "MedicalWebPage", "name": "Crise blastique", "alternateName": "Blast Crisis", "url": "https://questionsmedicales.fr/mesh/D001752", "about": { "@type": "MedicalCondition", "name": "Crise blastique", "code": { "@type": "MedicalCode", "code": "D001752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.098.500.110" } } }, { "@type": "MedicalWebPage", "name": "Cocancérogenèse", "alternateName": "Cocarcinogenesis", "url": "https://questionsmedicales.fr/mesh/D003043", "about": { "@type": "MedicalCondition", "name": "Cocancérogenèse", "code": { "@type": "MedicalCode", "code": "D003043", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.098.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Invasion tumorale", "alternateName": "Neoplasm Invasiveness", "url": "https://questionsmedicales.fr/mesh/D009361", "about": { "@type": "MedicalCondition", "name": "Invasion tumorale", "code": { "@type": "MedicalCode", "code": "D009361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.645" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Infiltration leucémique", "alternateName": "Leukemic Infiltration", "url": "https://questionsmedicales.fr/mesh/D017254", "about": { "@type": "MedicalCondition", "name": "Infiltration leucémique", "code": { "@type": "MedicalCode", "code": "D017254", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.645.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Métastase tumorale", "alternateName": "Neoplasm Metastasis", "url": "https://questionsmedicales.fr/mesh/D009362", "about": { "@type": "MedicalCondition", "name": "Métastase tumorale", "code": { "@type": "MedicalCode", "code": "D009362", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.650" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Extension extranodale", "alternateName": "Extranodal Extension", "url": "https://questionsmedicales.fr/mesh/D000079822", "about": { "@type": "MedicalCondition", "name": "Extension extranodale", "code": { "@type": "MedicalCode", "code": "D000079822", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.650.280" } } }, { "@type": "MedicalWebPage", "name": "Métastase lymphatique", "alternateName": "Lymphatic Metastasis", "url": "https://questionsmedicales.fr/mesh/D008207", "about": { "@type": "MedicalCondition", "name": "Métastase lymphatique", "code": { "@type": "MedicalCode", "code": "D008207", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.650.560" } } }, { "@type": "MedicalWebPage", "name": "Micrométastase tumorale", "alternateName": "Neoplasm Micrometastasis", "url": "https://questionsmedicales.fr/mesh/D061206", "about": { "@type": "MedicalCondition", "name": "Micrométastase tumorale", "code": { "@type": "MedicalCode", "code": "D061206", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.650.695" } } }, { "@type": "MedicalWebPage", "name": "Essaimage tumoral", "alternateName": "Neoplasm Seeding", "url": "https://questionsmedicales.fr/mesh/D009366", "about": { "@type": "MedicalCondition", "name": "Essaimage tumoral", "code": { "@type": "MedicalCode", "code": "D009366", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.650.830" } } }, { "@type": "MedicalWebPage", "name": "Métastases d'origine inconnue", "alternateName": "Neoplasms, Unknown Primary", "url": "https://questionsmedicales.fr/mesh/D009382", "about": { "@type": "MedicalCondition", "name": "Métastases d'origine inconnue", "code": { "@type": "MedicalCode", "code": "D009382", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.650.895" } } }, { "@type": "MedicalWebPage", "name": "Cellules tumorales circulantes", "alternateName": "Neoplastic Cells, Circulating", "url": "https://questionsmedicales.fr/mesh/D009360", "about": { "@type": "MedicalCondition", "name": "Cellules tumorales circulantes", "code": { "@type": "MedicalCode", "code": "D009360", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.650.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Récidive tumorale locale", "alternateName": "Neoplasm Recurrence, Local", "url": "https://questionsmedicales.fr/mesh/D009364", "about": { "@type": "MedicalCondition", "name": "Récidive tumorale locale", "code": { "@type": "MedicalCode", "code": "D009364", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.655" } } }, { "@type": "MedicalWebPage", "name": "Maladie résiduelle", "alternateName": "Neoplasm, Residual", "url": "https://questionsmedicales.fr/mesh/D018365", "about": { "@type": "MedicalCondition", "name": "Maladie résiduelle", "code": { "@type": "MedicalCode", "code": "D018365", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.700" } } }, { "@type": "MedicalWebPage", "name": "Dépendance oncogène", "alternateName": "Oncogene Addiction", "url": "https://questionsmedicales.fr/mesh/D000074723", "about": { "@type": "MedicalCondition", "name": "Dépendance oncogène", "code": { "@type": "MedicalCode", "code": "D000074723", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.850" } } } ], "about": { "@type": "MedicalCondition", "name": "Processus néoplasiques", "alternateName": "Neoplastic Processes", "code": { "@type": "MedicalCode", "code": "D009385", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Barbara A Centeno", "url": "https://questionsmedicales.fr/author/Barbara%20A%20Centeno", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA, Barbara.Centeno@moffitt.org." } }, { "@type": "Person", "name": "Sarah C Thomas", "url": "https://questionsmedicales.fr/author/Sarah%20C%20Thomas", "affiliation": { "@type": "Organization", "name": "Office of Chief Medical Examiner, New York, New York, USA." } }, { "@type": "Person", "name": "Guoqiang Zeng", "url": "https://questionsmedicales.fr/author/Guoqiang%20Zeng", "affiliation": { "@type": "Organization", "name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China." } }, { "@type": "Person", "name": "Honglan Zhou", "url": "https://questionsmedicales.fr/author/Honglan%20Zhou", "affiliation": { "@type": "Organization", "name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China." } }, { "@type": "Person", "name": "Yuantao Wang", "url": "https://questionsmedicales.fr/author/Yuantao%20Wang", "affiliation": { "@type": "Organization", "name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. Electronic address: wangyuantaobs@jlu.edu.cn." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Chemical Mutagenesis Approach to Insert Post-translational Modifications in Aggregation-Prone Proteins.", "datePublished": "2022-05-24", "url": "https://questionsmedicales.fr/article/35609278", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acschemneuro.2c00077" } }, { "@type": "ScholarlyArticle", "name": "Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways.", "datePublished": "2022-06-20", "url": "https://questionsmedicales.fr/article/35795661", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.898724" } }, { "@type": "ScholarlyArticle", "name": "Modeling Side Chains in the Three-Dimensional Structure of Proteins for Post-Translational Modifications.", "datePublished": "2023-08-30", "url": "https://questionsmedicales.fr/article/37686234", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms241713431" } }, { "@type": "ScholarlyArticle", "name": "Multi-protein assemblies orchestrate co-translational enzymatic processing on the human ribosome.", "datePublished": "2024-09-03", "url": "https://questionsmedicales.fr/article/39227397", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-024-51964-9" } }, { "@type": "ScholarlyArticle", "name": "Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters.", "datePublished": "2022-10-27", "url": "https://questionsmedicales.fr/article/36302660", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1124/molpharm.122.000604" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Processus néoplasiques", "item": "https://questionsmedicales.fr/mesh/D009385" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Processus néoplasiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Processus néoplasiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Processus néoplasiques", "description": "Comment diagnostiquer un cancer ?\nQuels tests sont utilisés pour le dépistage ?\nQu'est-ce qu'une biopsie ?\nQuels sont les marqueurs tumoraux ?\nComment évaluer le stade d'un cancer ?", "url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Processus néoplasiques", "description": "Quels sont les symptômes courants du cancer ?\nComment reconnaître une tumeur ?\nQuels signes indiquent un cancer avancé ?\nLes symptômes varient-ils selon le type de cancer ?\nQu'est-ce que la cachexie ?", "url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Processus néoplasiques", "description": "Comment prévenir le cancer ?\nLe vaccin contre le HPV prévient-il le cancer ?\nQuels aliments aident à prévenir le cancer ?\nL'exercice physique réduit-il le risque de cancer ?\nLe dépistage précoce est-il important ?", "url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Processus néoplasiques", "description": "Quels sont les traitements standards du cancer ?\nQu'est-ce que l'immunothérapie ?\nComment fonctionne la radiothérapie ?\nQuels sont les effets secondaires de la chimiothérapie ?\nQuand est-ce que la chirurgie est nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Processus néoplasiques", "description": "Quelles sont les complications du cancer ?\nComment les métastases affectent-elles le traitement ?\nQu'est-ce que la douleur cancéreuse ?\nLes traitements peuvent-ils causer des complications ?\nComment gérer les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Processus néoplasiques", "description": "Quels sont les principaux facteurs de risque du cancer ?\nL'hérédité joue-t-elle un rôle dans le cancer ?\nLe stress est-il un facteur de risque ?\nL'exposition à des produits chimiques augmente-t-elle le risque ?\nL'alimentation influence-t-elle le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un cancer ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des examens cliniques, imageries et biopsies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le dépistage ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent mammographies, coloscopies et tests sanguins spécifiques." } }, { "@type": "Question", "name": "Qu'est-ce qu'une biopsie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie consiste à prélever un échantillon de tissu pour analyse histologique." } }, { "@type": "Question", "name": "Quels sont les marqueurs tumoraux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs tumoraux sont des substances produites par les cellules cancéreuses, détectables dans le sang." } }, { "@type": "Question", "name": "Comment évaluer le stade d'un cancer ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le stade est évalué par des examens d'imagerie et des classifications comme TNM." } }, { "@type": "Question", "name": "Quels sont les symptômes courants du cancer ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, perte de poids, douleurs et changements cutanés." } }, { "@type": "Question", "name": "Comment reconnaître une tumeur ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une tumeur peut se manifester par une masse palpable, des douleurs ou des changements fonctionnels." } }, { "@type": "Question", "name": "Quels signes indiquent un cancer avancé ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des douleurs persistantes, des saignements inexpliqués et des troubles respiratoires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de cancer ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque type de cancer présente des symptômes spécifiques selon l'organe touché." } }, { "@type": "Question", "name": "Qu'est-ce que la cachexie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La cachexie est une perte de poids et de masse musculaire souvent associée au cancer." } }, { "@type": "Question", "name": "Comment prévenir le cancer ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut un mode de vie sain, l'évitement du tabac et des dépistages réguliers." } }, { "@type": "Question", "name": "Le vaccin contre le HPV prévient-il le cancer ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vaccin contre le HPV réduit le risque de cancers liés au virus, comme le cancer du col." } }, { "@type": "Question", "name": "Quels aliments aident à prévenir le cancer ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les fruits, légumes, grains entiers et aliments riches en antioxydants sont bénéfiques." } }, { "@type": "Question", "name": "L'exercice physique réduit-il le risque de cancer ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier est associé à un risque réduit de plusieurs types de cancer." } }, { "@type": "Question", "name": "Le dépistage précoce est-il important ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce permet de détecter le cancer à un stade plus traitable." } }, { "@type": "Question", "name": "Quels sont les traitements standards du cancer ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent chirurgie, chimiothérapie, radiothérapie et immunothérapie." } }, { "@type": "Question", "name": "Qu'est-ce que l'immunothérapie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'immunothérapie utilise le système immunitaire pour combattre les cellules cancéreuses." } }, { "@type": "Question", "name": "Comment fonctionne la radiothérapie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La radiothérapie utilise des rayonnements pour détruire les cellules cancéreuses." } }, { "@type": "Question", "name": "Quels sont les effets secondaires de la chimiothérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections." } }, { "@type": "Question", "name": "Quand est-ce que la chirurgie est nécessaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est souvent nécessaire pour retirer des tumeurs localisées ou pour un diagnostic." } }, { "@type": "Question", "name": "Quelles sont les complications du cancer ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent métastases, infections, et effets secondaires des traitements." } }, { "@type": "Question", "name": "Comment les métastases affectent-elles le traitement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les métastases compliquent le traitement et peuvent nécessiter des approches plus agressives." } }, { "@type": "Question", "name": "Qu'est-ce que la douleur cancéreuse ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La douleur cancéreuse est causée par la tumeur ou les traitements, nécessitant une gestion adéquate." } }, { "@type": "Question", "name": "Les traitements peuvent-ils causer des complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements comme la chimiothérapie peuvent entraîner des complications comme des infections." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires des traitements ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut des médicaments, des soins de soutien et des conseils nutritionnels." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du cancer ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'alcool, l'obésité et l'exposition à des agents carcinogènes." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans le cancer ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer augmentent le risque de certains types de cancer." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut influencer le risque de cancer, bien que les preuves soient variées." } }, { "@type": "Question", "name": "L'exposition à des produits chimiques augmente-t-elle le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des produits chimiques comme l'amiante ou le benzène est un facteur de risque." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque de cancer ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses et pauvre en fibres peut augmenter le risque de cancer." } } ] } ] }

Sources (10000 au total)

Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters.

Drug transporters are modulators for drug absorption, distribution, and excretion. Key drug transporters including P-glycoprotein and breast cancer resistance protein of the ABC superfamily; organic a...

Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell Models.

Facioscapulohumeral muscular dystrophy (FSHD) is caused by abnormal de-repression of the myotoxic transcription factor DUX4. Although the transcriptional targets of DUX4 are known, the regulation of D... We immunoprecipitated DUX4 protein and performed mass spectrometry to identify PTMs. We then characterized DUX4 PTMs and potential enzyme modifiers using mutagenesis, proteomics, and biochemical assay... We identified 17 DUX4 amino acids with PTMs, and generated 55 DUX4 mutants designed to prevent or mimic PTMs. Five mutants protected cells against DUX4-mediated toxicity and reduced the ability of DUX... These results support that DUX4 is regulated by PTMs and set a foundation for developing FSHD drug screens based mechanistically on DUX4 PTMs and modifying enzymes. ANN NEUROL 2023;94:398-413....